Eisai Inc. was established in 1995 and began marketing its first product in the United States in 1997. Since then we have rapidly grown to become a fully integrated pharmaceutical business. Eisai's areas of com...
Eisai Inc. was established in 1995 and began marketing its first product in the United States in 1997. Since then we have rapidly grown to become a fully integrated pharmaceutical business. Eisai's areas of commercial focus include neurology, gastrointestinal disorders and oncology/critical care. The company serves as the U.S. pharmaceutical operation of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world.
Eisai has a global product creation organization that includes U.S.-based R&D facilities in Massachusetts, New Jersey, North Carolina and Pennsylvania as well as manufacturing facilities in Maryland and North Carolina. The company's areas of R&D focus include neuroscience; oncology; vascular, inflammatory and immunological reaction; and antibody-based programs.
Eisai recognizes that we are the Company's greatest asset. To this, Eisai is committed to providing us an enabling and empowering work environment that allows us to grow and thrive. In our diverse organization, we adhere to a strict commitment to our values of Integrity, Respect, Professionalism, Quality and Teamwork. We therefore invite you to explore this job opportunity or any others that may match your qualifications and interests.
This profile is an official LinkedIn page for Eisai Inc. in the United States. Please also visit our website at www.eisai.com/us.
Comments and posts by users on this site are not created or controlled by Eisai Inc. and Eisai is not responsible for such content.
Eisai is a human health care company that provides products and services to its patients and their families under any healthcare system. Eisai specializes in the integrated pharmaceutical business that operates in business groups it focuses on oncology and neurology, dementia-related diseases and neurodegenerative diseases.
The company was founded in 1941 and headquartered in Tokyo, Japan.